Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04BGT
|
||||
| Former ID |
DNC010608
|
||||
| Drug Name |
4-propyl-6-m-tolylpyrimidine-2-carbonitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531005] | ||
| Formula |
C15H15N3
|
||||
| Canonical SMILES |
CCCC1=NC(=NC(=C1)C2=CC(=CC=C2)C)C#N
|
||||
| InChI |
1S/C15H15N3/c1-3-5-13-9-14(18-15(10-16)17-13)12-7-4-6-11(2)8-12/h4,6-9H,3,5H2,1-2H3
|
||||
| InChIKey |
LWTLVKKUNGVFHE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | Inhibitor | [531005] | |
| Cathepsin S | Target Info | Inhibitor | [531005] | ||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.